-
1
-
-
0020622131
-
Factor X abnormalities
-
Mammen EF. Factor X abnormalities. Sem Thromb Haemost 1983; 9:31-44.
-
(1983)
Sem Thromb Haemost
, vol.9
, pp. 31-44
-
-
Mammen, E.F.1
-
2
-
-
0022438103
-
Tentative and updated classification of factor X variants
-
Girolami A. Tentative and updated classification of factor X variants. Acta Haemato 1986; 75:58-9.
-
(1986)
Acta Haemato
, vol.75
, pp. 58-59
-
-
Girolami, A.1
-
3
-
-
0014666302
-
Abnormal forms of factor X
-
Denson KWE. Abnormal forms of factor X. Lancet 1969; 2:1256.
-
(1969)
Lancet
, vol.2
, pp. 1256
-
-
Denson, K.W.E.1
-
4
-
-
0021988726
-
Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses
-
Fair DS, Edgington TS. Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses. Br J Haematol 1985; 59:235-48.
-
(1985)
Br J Haematol
, vol.59
, pp. 235-248
-
-
Fair, D.S.1
Edgington, T.S.2
-
5
-
-
1842396185
-
Coagulation factor synthesis by the liver with special reference to factors V and VIII
-
Fondu P and Thijs O (eds). Martinus Nijhoff Boston
-
Giddings JC. Coagulation factor synthesis by the liver with special reference to factors V and VIII. In Fondu P and Thijs O (eds). Hemostatic Failure in Liver Disease. Martinus Nijhoff Boston, 1984; pp.5-21.
-
(1984)
Hemostatic Failure in Liver Disease
, pp. 5-21
-
-
Giddings, J.C.1
-
6
-
-
0020427478
-
Rat factor X is synthesized as a single chain precursor inducible by prothrombin fragments
-
Graves CB, Munns TW, Willingham AK, Stauss AW. Rat factor X is synthesized as a single chain precursor inducible by prothrombin fragments. J Biol Chem 1982; 257:13108-13.
-
(1982)
J Biol Chem
, vol.257
, pp. 13108-13113
-
-
Graves, C.B.1
Munns, T.W.2
Willingham, A.K.3
Stauss, A.W.4
-
7
-
-
0021259955
-
Human hepatoma cells secrete single chain factor X, prothrombin and antithrombin III
-
Fair DS, Bahnak BR. Human hepatoma cells secrete single chain factor X, prothrombin and antithrombin III. Blood 1984; 64: 194-204.
-
(1984)
Blood
, vol.64
, pp. 194-204
-
-
Fair, D.S.1
Bahnak, B.R.2
-
8
-
-
0018672139
-
Combined functional and immunochemical analysis of normal and abnormal human factor X
-
Fair DS, Plow EF, Edgington TS. Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest 1979; 64:884-94.
-
(1979)
J Clin Invest
, vol.64
, pp. 884-894
-
-
Fair, D.S.1
Plow, E.F.2
Edgington, T.S.3
-
9
-
-
0028783339
-
Plasma levels of protein S, protein C and factor X:Effects of sex, hormonal state and age
-
Henkens CM, Bom VJ, Van der Schaaf W, Pelsma PM, Sibinga CT, de Kam PJ, Van der Meer J. Plasma levels of protein S, protein C and factor X:effects of sex, hormonal state and age. Thromb Haemost 1995; 74:1271-5.
-
(1995)
Thromb Haemost
, vol.74
, pp. 1271-1275
-
-
Henkens, C.M.1
Bom, V.J.2
Van Der Schaaf, W.3
Pelsma, P.M.4
Sibinga, C.T.5
De Kam, P.J.6
Van Der Meer, J.7
-
10
-
-
0026588358
-
Processing and trafficking of clotting factor X in the secretory pathway. Effects of warfarin
-
Stanton C, Wallin R. Processing and trafficking of clotting factor X in the secretory pathway. Effects of warfarin. Biochem J 1992; 284:25-31.
-
(1992)
Biochem J
, vol.284
, pp. 25-31
-
-
Stanton, C.1
Wallin, R.2
-
11
-
-
0001506214
-
Activation of bovine factor X (Stuart factor): Conversion of activation of factor Xaa to Xab
-
Fujikawa K, Titani K, Davie EW. Activation of bovine factor X (Stuart factor): conversion of activation of factor Xaa to Xab. Proc Natl Acad Sci USA 1975:72:3359-63.
-
(1975)
Proc Natl Acad Sci USA
, vol.72
, pp. 3359-3363
-
-
Fujikawa, K.1
Titani, K.2
Davie, E.W.3
-
12
-
-
0028101918
-
Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa
-
Altieri DC. Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa. J Biol Chem 1994; 269:3139-42.
-
(1994)
J Biol Chem
, vol.269
, pp. 3139-3142
-
-
Altieri, D.C.1
-
13
-
-
0029095017
-
Xa receptor EPR-1
-
Altieri DC. Xa receptor EPR-1. FASEB J 1995; 9:860-5.
-
(1995)
FASEB J
, vol.9
, pp. 860-865
-
-
Altieri, D.C.1
-
14
-
-
0030042202
-
Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding
-
Ambrosini G, Altieri DC. Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding. J Biol Chem 1996; 271:1243-8.
-
(1996)
J Biol Chem
, vol.271
, pp. 1243-1248
-
-
Ambrosini, G.1
Altieri, D.C.2
-
15
-
-
0022535992
-
Activation of coagulation releases endothelial cell mitogens
-
Gajdusek C, Carbon S, Ross R, Nawroth P, Stern D. Activation of coagulation releases endothelial cell mitogens. J Cell Biol 1986; 103:419-28.
-
(1986)
J Cell Biol
, vol.103
, pp. 419-428
-
-
Gajdusek, C.1
Carbon, S.2
Ross, R.3
Nawroth, P.4
Stern, D.5
-
16
-
-
0026535444
-
Coagulation factors X, Xa and protein S as potent mitogens of cultured aortic smooth muscle cells
-
Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 1992; 89:2317-20.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 2317-2320
-
-
Gasic, G.P.1
Arenas, C.P.2
Gasic, T.B.3
Gasic, G.J.4
-
17
-
-
0029989386
-
Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa
-
Nicholson AC, Nachman RL, Altieri DC, Summers BD, Ruf W, Edgington TS, Hajjar DP. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem 1996; 271:28407-13.
-
(1996)
J Biol Chem
, vol.271
, pp. 28407-28413
-
-
Nicholson, A.C.1
Nachman, R.L.2
Altieri, D.C.3
Summers, B.D.4
Ruf, W.5
Edgington, T.S.6
Hajjar, D.P.7
-
18
-
-
0027304964
-
Structure of human des(1-45) factor Xa at 2.2Å resolution
-
Padmanabhan K, Padmanabhan KP, Tulinsky A, Park CH, Bode W, Huber R, Blankenship DT, Cardin AD, Kisiel W. Structure of human des(1-45) factor Xa at 2.2Å resolution. J Mol Biol 1993; 232:947-66.
-
(1993)
J Mol Biol
, vol.232
, pp. 947-966
-
-
Padmanabhan, K.1
Padmanabhan, K.P.2
Tulinsky, A.3
Park, C.H.4
Bode, W.5
Huber, R.6
Blankenship, D.T.7
Cardin, A.D.8
Kisiel, W.9
-
19
-
-
0028168831
-
2+ binding site yet retains function
-
2+ binding site yet retains function. J Biol Chem 1994; 269:21495-9.
-
(1994)
J Biol Chem
, vol.269
, pp. 21495-21499
-
-
Rezaie, A.R.1
Esmon, C.T.2
-
21
-
-
0030054839
-
A binding site on the surface of activated human platelets is shared by factor X and prothrombin
-
Scandura JM, Ahmad SS, Walsh PN. A binding site on the surface of activated human platelets is shared by factor X and prothrombin. Biochemistry 1996; 35:8890-902.
-
(1996)
Biochemistry
, vol.35
, pp. 8890-8902
-
-
Scandura, J.M.1
Ahmad, S.S.2
Walsh, P.N.3
-
22
-
-
0028045068
-
Human monocytes support factor X activation by factor VIIa, independent of tissue factor: Implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia
-
Hoffman M, Monroe DM, Roberts HR. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia. Blood 1994; 83:38-42.
-
(1994)
Blood
, vol.83
, pp. 38-42
-
-
Hoffman, M.1
Monroe, D.M.2
Roberts, H.R.3
-
23
-
-
0028241067
-
The activation of human blood coagulation factor X on the surface of endothelial cells: A comparison with various vascular cells, platelets and monocytes
-
Brinkman H-JM, Mertens K, Holthuis J, Zwart-Huinink LA, Grijm K, Van Mourik JA. The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes. Brit J Haematol 1994; 87:332-42.
-
(1994)
Brit J Haematol
, vol.87
, pp. 332-342
-
-
Brinkman, H.-J.M.1
Mertens, K.2
Holthuis, J.3
Zwart-Huinink, L.A.4
Grijm, K.5
Van Mourik, J.A.6
-
24
-
-
0024346843
-
Platelet receptor occupancy with factor IXa promotes factor X activation
-
Ahmad SS, Rawala-Sheikh R, Walsh P. Platelet receptor occupancy with factor IXa promotes factor X activation. J Biol Chem 1989; 264:20012-6.
-
(1989)
J Biol Chem
, vol.264
, pp. 20012-20016
-
-
Ahmad, S.S.1
Rawala-Sheikh, R.2
Walsh, P.3
-
25
-
-
0019831499
-
The role of phospholipid and FVIIIa in the activation of bovine factor X
-
van Diejen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and FVIIIa in the activation of bovine factor X. J Biol Chem 1981; 256:3433-42.
-
(1981)
J Biol Chem
, vol.256
, pp. 3433-3442
-
-
Van Diejen, G.1
Tans, G.2
Rosing, J.3
Hemker, H.C.4
-
26
-
-
0027302704
-
The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor
-
ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 1993; 92:1207-12.
-
(1993)
J Clin Invest
, vol.92
, pp. 1207-1212
-
-
Ten Cate, H.1
Bauer, K.A.2
Levi, M.3
Edgington, T.S.4
Sublett, R.D.5
Barzegar, S.6
Kass, B.L.7
Rosenberg, R.D.8
-
28
-
-
0025010978
-
Proteolytic activation of human factors IX and X by recombinant human factor VIIa: Effects of calcium, phospholipids and tissue factor
-
Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: Effects of calcium, phospholipids and tissue factor. Biochemistry 1990; 29:9418-25.
-
(1990)
Biochemistry
, vol.29
, pp. 9418-9425
-
-
Komiyama, Y.1
Pedersen, A.H.2
Kisiel, W.3
-
29
-
-
0020654344
-
A monoclonal antibody which inhibits the factor Va:Factor Xa interaction
-
Tucker MM, Foster WB, Katzmann JA, Mann KG. A monoclonal antibody which inhibits the factor Va:factor Xa interaction. J Biol Chem 1983; 258:1210-4.
-
(1983)
J Biol Chem
, vol.258
, pp. 1210-1214
-
-
Tucker, M.M.1
Foster, W.B.2
Katzmann, J.A.3
Mann, K.G.4
-
30
-
-
0023185058
-
Epitope mapping of functional domains of human factor V with murine monoclonal antibodies
-
Annamalai AE, Rao RK, Chin HCC et al. Epitope mapping of functional domains of human factor V with murine monoclonal antibodies. Blood 1987; 70:139-46.
-
(1987)
Blood
, vol.70
, pp. 139-146
-
-
Annamalai, A.E.1
Rao, R.K.2
Chin, H.C.C.3
-
31
-
-
0021322174
-
Comparison of coagulation factor Xa and des-(1-44) factor Xa in the assembly of prothrombinase
-
Skogen WF, Esmon CT, Cox AC. Comparison of coagulation factor Xa and des-(1-44) factor Xa in the assembly of prothrombinase. J Biol Chem 1984; 259:2306-10.
-
(1984)
J Biol Chem
, vol.259
, pp. 2306-2310
-
-
Skogen, W.F.1
Esmon, C.T.2
Cox, A.C.3
-
32
-
-
0025812794
-
The γ-carboxyglutamic acid and epidermal growth factor-like domains of factor X
-
Persson E, Valcarce C, Stenflo J. The γ-carboxyglutamic acid and epidermal growth factor-like domains of factor X. J Biol Chem 1991; 266:2453-8.
-
(1991)
J Biol Chem
, vol.266
, pp. 2453-2458
-
-
Persson, E.1
Valcarce, C.2
Stenflo, J.3
-
33
-
-
0029036487
-
Factor Xa-factor Va complex assembles in two dimensions with unexpectedly high affinity: An experimental and theoretical analysis
-
Ye J, Esmon CT. Factor Xa-factor Va complex assembles in two dimensions with unexpectedly high affinity: an experimental and theoretical analysis. Biochemistry 1995; 34:6448-53.
-
(1995)
Biochemistry
, vol.34
, pp. 6448-6453
-
-
Ye, J.1
Esmon, C.T.2
-
34
-
-
0029133654
-
R506Q by activated protein C
-
R506Q by activated protein C. J Biol Chem 1995; 270:21158-66.
-
(1995)
J Biol Chem
, vol.270
, pp. 21158-21166
-
-
Nicolaes, G.A.F.1
Tans, G.2
Thomassen, C.L.G.D.3
Hemker, H.C.4
Pabinger, I.5
Varadi, K.6
Schwarz, H.P.7
Rosing, J.8
-
35
-
-
0026695765
-
Construction, expression and characterization of a chimera of factor IX and factor X
-
Hertzberg MS, Ben-Tal O, Furie B, Furie BC. Construction, expression and characterization of a chimera of factor IX and factor X. J Biol Chem 1992; 267:14759-66.
-
(1992)
J Biol Chem
, vol.267
, pp. 14759-14766
-
-
Hertzberg, M.S.1
Ben-Tal, O.2
Furie, B.3
Furie, B.C.4
-
36
-
-
0026710630
-
Molecular recognition sites on factor Xa which participate in the prothrombinase complex
-
Chattopadhyay A, James HL, Fair DS. Molecular recognition sites on factor Xa which participate in the prothrombinase complex. J Biol Chem 1992; 267:12323-9.
-
(1992)
J Biol Chem
, vol.267
, pp. 12323-12329
-
-
Chattopadhyay, A.1
James, H.L.2
Fair, D.S.3
-
37
-
-
0029131205
-
Characterization of the binding of factor Xa to fibrinogen/fibrin derivatives and localization of the factor Xa binding site on fibrinogen
-
Iino M, Takeya H, Takemitsu T, Nakagaki T, Gabazza EC, Suzuki K. Characterization of the binding of factor Xa to fibrinogen/fibrin derivatives and localization of the factor Xa binding site on fibrinogen. Eur J Biochem 1995; 232:90-7.
-
(1995)
Eur J Biochem
, vol.232
, pp. 90-97
-
-
Iino, M.1
Takeya, H.2
Takemitsu, T.3
Nakagaki, T.4
Gabazza, E.C.5
Suzuki, K.6
-
38
-
-
0027199974
-
Importance of factor Xa in determining the procoagulant activity of whole-blood clots
-
Eisenberg PR, Siegel JE, Abendschein DR, Miletich JP. Importance of factor Xa in determining the procoagulant activity of whole-blood clots. J Clin Invest 1993; 91:1877-83.
-
(1993)
J Clin Invest
, vol.91
, pp. 1877-1883
-
-
Eisenberg, P.R.1
Siegel, J.E.2
Abendschein, D.R.3
Miletich, J.P.4
-
39
-
-
0029028011
-
Prothrombinase components can accelerate tissue plasminogen activator-catalyzed plasminogen activation
-
Pryzdial ELG, Bajzar L, Nesheim ME. Prothrombinase components can accelerate tissue plasminogen activator-catalyzed plasminogen activation. J Biol Chem 1995; 270:17871-7.
-
(1995)
J Biol Chem
, vol.270
, pp. 17871-17877
-
-
Pryzdial, E.L.G.1
Bajzar, L.2
Nesheim, M.E.3
-
40
-
-
0029938845
-
Autoproteolysis or plasmin-mediated cleavage of factor Xaα exposes a plasminogen binding site and inhibits coagulation
-
Pryzdial ELG, Kessler GE. Autoproteolysis or plasmin-mediated cleavage of factor Xaα exposes a plasminogen binding site and inhibits coagulation. J Biol Chem 1996; 271:16614-20.
-
(1996)
J Biol Chem
, vol.271
, pp. 16614-16620
-
-
Pryzdial, E.L.G.1
Kessler, G.E.2
-
41
-
-
0030008810
-
Kinetics of blood coagulation factor Xaα autoproteolytic conversion to factor Xaβ
-
Pryzdial ELG, Kessler GE. Kinetics of blood coagulation factor Xaα autoproteolytic conversion to factor Xaβ. J Biol Chem 1996; 271: 16621-6.
-
(1996)
J Biol Chem
, vol.271
, pp. 16621-16626
-
-
Pryzdial, E.L.G.1
Kessler, G.E.2
-
42
-
-
0027724106
-
Kinetics of factor Xa inhibition by tissue factor pathway inhibitor
-
Huang Z-F, Wun T-C, Broze GJ. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem 1993; 268:26950-5.
-
(1993)
J Biol Chem
, vol.268
, pp. 26950-26955
-
-
Huang, Z.-F.1
Wun, T.-C.2
Broze, G.J.3
-
43
-
-
0028154010
-
Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor
-
Lindhout T, Willems G, Blezer R, Hemker HC. Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor. Biochem J 1994; 297:131-6.
-
(1994)
Biochem J
, vol.297
, pp. 131-136
-
-
Lindhout, T.1
Willems, G.2
Blezer, R.3
Hemker, H.C.4
-
44
-
-
0028932993
-
Tissue factor pathway inhibitor and the revised theory of coagulation
-
Broze GJ. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med 1995; 46:103-12.
-
(1995)
Annu Rev Med
, vol.46
, pp. 103-112
-
-
Broze, G.J.1
-
45
-
-
0029983760
-
Receptor-mediated endocytosis of coagulation factor Xa requires cell surface-bound tissue factor pathway inhibitor
-
Ho G, Toomey JR, Broze GJ, Schwartz AL. Receptor-mediated endocytosis of coagulation factor Xa requires cell surface-bound tissue factor pathway inhibitor. J Biol Chem 1996; 271:9497-502.
-
(1996)
J Biol Chem
, vol.271
, pp. 9497-9502
-
-
Ho, G.1
Toomey, J.R.2
Broze, G.J.3
Schwartz, A.L.4
-
46
-
-
0021233471
-
Inhibition of human activated factor X by antithrombin III and α-proteinase inhibitor in human plasma
-
Gitel SN, Medina VM, Wessler S. Inhibition of human activated factor X by antithrombin III and α-proteinase inhibitor in human plasma. J Biol Chem 1984; 259:6890-5.
-
(1984)
J Biol Chem
, vol.259
, pp. 6890-6895
-
-
Gitel, S.N.1
Medina, V.M.2
Wessler, S.3
-
47
-
-
0027199974
-
Importance of factor Xa in determining the procoagulant activity of whole-blood clots
-
Eisenberg PR, Siegel JE, Abendschein DR, Miletich JP. Importance of factor Xa in determining the procoagulant activity of whole-blood clots. J Clin Invest 1993; 91:1877-83.
-
(1993)
J Clin Invest
, vol.91
, pp. 1877-1883
-
-
Eisenberg, P.R.1
Siegel, J.E.2
Abendschein, D.R.3
Miletich, J.P.4
-
48
-
-
0028072085
-
Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator
-
Barrow RT, Parker ET, Krishnaswamy S, Lollar P. Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator. J Biol Chem 1994; 269:26796-800.
-
(1994)
J Biol Chem
, vol.269
, pp. 26796-26800
-
-
Barrow, R.T.1
Parker, E.T.2
Krishnaswamy, S.3
Lollar, P.4
-
49
-
-
0023731990
-
Kinetics of inactivation of membrane bound factor Va by activated protein C. Protein S modulates factor Xa ptotection
-
Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane bound factor Va by activated protein C. Protein S modulates factor Xa ptotection. J Biol Chem 1988; 263:14884-90.
-
(1988)
J Biol Chem
, vol.263
, pp. 14884-14890
-
-
Solymoss, S.1
Tucker, M.M.2
Tracy, P.B.3
-
50
-
-
0028213899
-
Protein S binds to and inhibits factor Xa
-
Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 1994; 91:2728-32.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 2728-2732
-
-
Heeb, M.J.1
Rosing, J.2
Bakker, H.M.3
Fernandez, J.A.4
Tans, G.5
Griffin, J.H.6
-
51
-
-
0028855424
-
Inhibition of the intrinsic factor X activating complex by protein S: Evidence for a specific binding of protein S to factor VIII
-
Koppelman SJ, Hackeng TM, Sixma JJ, Bouma BN. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII. Blood 1995; 86: 1062-71.
-
(1995)
Blood
, vol.86
, pp. 1062-1071
-
-
Koppelman, S.J.1
Hackeng, T.M.2
Sixma, J.J.3
Bouma, B.N.4
-
52
-
-
0029118512
-
Synergistic inhibition of the intrinsic factor X activation activation by protein S and C4b-binding protein
-
Koppelman SJ, van't Veer C, Sixma JJ, Bouma BN. Synergistic inhibition of the intrinsic factor X activation activation by protein S and C4b-binding protein. Blood 1995; 86:2653-60.
-
(1995)
Blood
, vol.86
, pp. 2653-2660
-
-
Koppelman, S.J.1
Van't Veer, C.2
Sixma, J.J.3
Bouma, B.N.4
-
53
-
-
0028030891
-
Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa
-
Hackeng TM, van't Veer C, Meijers JCM, Bouma BN. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem 1994; 269:21051-8.
-
(1994)
J Biol Chem
, vol.269
, pp. 21051-21058
-
-
Hackeng, T.M.1
Van't Veer, C.2
Meijers, J.C.M.3
Bouma, B.N.4
-
54
-
-
0022871419
-
Gene for human factor X: A blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C
-
Leytus SP, Foster DC, Kurachi K, Davie EW. Gene for human factor X: A blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry 1986; 25: 5098-102.
-
(1986)
Biochemistry
, vol.25
, pp. 5098-5102
-
-
Leytus, S.P.1
Foster, D.C.2
Kurachi, K.3
Davie, E.W.4
-
55
-
-
0025910104
-
Cloning and expression in COS-1 cells of a full-length cDNA encoding human coagulation factor X
-
Messier TL, Pittman DD, Long GL, Kaufman RJ, Church WR. Cloning and expression in COS-1 cells of a full-length cDNA encoding human coagulation factor X. Gene 1991; 99:291-4.
-
(1991)
Gene
, vol.99
, pp. 291-294
-
-
Messier, T.L.1
Pittman, D.D.2
Long, G.L.3
Kaufman, R.J.4
Church, W.R.5
-
56
-
-
0021760465
-
Blood coagulation factor X mRNa encodes a single polypeptide chain containing a prepro leader sequence
-
Fung MR, Campbell RM, MacGillivray RTA. Blood coagulation factor X mRNA encodes a single polypeptide chain containing a prepro leader sequence. Nucleic Acids Res 1984; 12:4481-92.
-
(1984)
Nucleic Acids Res
, vol.12
, pp. 4481-4492
-
-
Fung, M.R.1
Campbell, R.M.2
MacGillivray, R.T.A.3
-
57
-
-
0028357936
-
Analysis of the partial nucleotide sequences and deduced primary structures of the protease domains of mammalian blood coagulation factors VII and X
-
Murakawa M, Okamura T, Kamura T, Kuroiwa M, Harada M, Niho Y. Analysis of the partial nucleotide sequences and deduced primary structures of the protease domains of mammalian blood coagulation factors VII and X. Eur J Haematol 1994; 52:162-8.
-
(1994)
Eur J Haematol
, vol.52
, pp. 162-168
-
-
Murakawa, M.1
Okamura, T.2
Kamura, T.3
Kuroiwa, M.4
Harada, M.5
Niho, Y.6
-
58
-
-
0029998990
-
Processing and expression of rat and human clotting factor X-encoding cDNAs
-
Stanton C, Ross RP, Hutson S, Wallin R. Processing and expression of rat and human clotting factor X-encoding cDNAs. Gene 1996; 169: 269-73.
-
(1996)
Gene
, vol.169
, pp. 269-273
-
-
Stanton, C.1
Ross, R.P.2
Hutson, S.3
Wallin, R.4
-
59
-
-
0024843766
-
Cloning and characterization of the 5′ end (exon 1) of the gene encoding human factor X
-
Jagadeeswaran P, Reddy SK, Rao KJ, Hamsabhushanam K, Lyman G. Cloning and characterization of the 5′ end (exon 1) of the gene encoding human factor X. Gene 1989; 84:517-9.
-
(1989)
Gene
, vol.84
, pp. 517-519
-
-
Jagadeeswaran, P.1
Reddy, S.K.2
Rao, K.J.3
Hamsabhushanam, K.4
Lyman, G.5
-
60
-
-
0029737765
-
Molecular reconstruction and homology modelling of the catalytic domain of the common ancestor of the haemostatic vitamin K-dependent serine proteinases
-
Krawczak M, Wacey A, Cooper DN. Molecular reconstruction and homology modelling of the catalytic domain of the common ancestor of the haemostatic vitamin K-dependent serine proteinases. Hum Genet 1996; 98:351-70.
-
(1996)
Hum Genet
, vol.98
, pp. 351-370
-
-
Krawczak, M.1
Wacey, A.2
Cooper, D.N.3
-
61
-
-
0022432550
-
Polymorphism associated with the coagulation factor X gene
-
Jaye M, Ricca G, Kaplan R, Howk R, Mudd R, Ngo KY, Fair DS, Drohan W. Polymorphism associated with the coagulation factor X gene. Nucleic Acids Res 1985; 13:8286.
-
(1985)
Nucleic Acids Res
, vol.13
, pp. 8286
-
-
Jaye, M.1
Ricca, G.2
Kaplan, R.3
Howk, R.4
Mudd, R.5
Ngo, K.Y.6
Fair, D.S.7
Drohan, W.8
-
62
-
-
0023888743
-
Multiple polymorphism sites in factor X locus
-
Hassan HJ, Guerriero R, Chelucci C, Leonardi A, Mattia G, Leone G, Mariani G, Mannucci PM, Peschle C. Multiple polymorphism sites in factor X locus. Blood 1988; 71:1353-6.
-
(1988)
Blood
, vol.71
, pp. 1353-1356
-
-
Hassan, H.J.1
Guerriero, R.2
Chelucci, C.3
Leonardi, A.4
Mattia, G.5
Leone, G.6
Mariani, G.7
Mannucci, P.M.8
Peschle, C.9
-
65
-
-
0022181227
-
The structural gene for human coagulation factor X is located on chromosome 13q34
-
Scambler PJ, Williamson R. The structural gene for human coagulation factor X is located on chromosome 13q34. Cytogenet. Cell Genet 1985; 39:231-3.
-
(1985)
Cytogenet. Cell Genet
, vol.39
, pp. 231-233
-
-
Scambler, P.J.1
Williamson, R.2
-
66
-
-
0022504302
-
Mapping through somatic cell hybrids and cDNA probes of protein C to chromosome 2, factor X to chromosome 13 and α1-acid glycoprotein to chromosome 9
-
Rocchi M, Roncuzzi L, Santamaria R, Archidiacono N, Dente L, Romeo G. Mapping through somatic cell hybrids and cDNA probes of protein C to chromosome 2, factor X to chromosome 13 and α1-acid glycoprotein to chromosome 9. Hum Genet 1986; 74:30-3.
-
(1986)
Hum Genet
, vol.74
, pp. 30-33
-
-
Rocchi, M.1
Roncuzzi, L.2
Santamaria, R.3
Archidiacono, N.4
Dente, L.5
Romeo, G.6
-
68
-
-
0026767457
-
Liver-specific expression of the gene coding for human factor X, a blood coagulation factor
-
Miao CH, Leytus SP, Chung DW, Davie EW. Liver-specific expression of the gene coding for human factor X, a blood coagulation factor. J Biol Chem 1992; 267:7395-401.
-
(1992)
J Biol Chem
, vol.267
, pp. 7395-7401
-
-
Miao, C.H.1
Leytus, S.P.2
Chung, D.W.3
Davie, E.W.4
-
69
-
-
0023113430
-
Steady state levels of factor X mRNA in liver and HepG2 cells
-
Bahnak BR, Howk R, Morrissey JH, Ricca GA, Edgington TS, Jaye MC, Drohan WW, Fair DS. Steady state levels of factor X mRNA in liver and HepG2 cells. Blood 1987; 69:224-30.
-
(1987)
Blood
, vol.69
, pp. 224-230
-
-
Bahnak, B.R.1
Howk, R.2
Morrissey, J.H.3
Ricca, G.A.4
Edgington, T.S.5
Jaye, M.C.6
Drohan, W.W.7
Fair, D.S.8
-
70
-
-
0030028515
-
Liver-enriched transcription factor HNF-4 and ubiquitous factor NF-Y are critical for expression of blood coagulation factor X
-
Hung HL, High KA. Liver-enriched transcription factor HNF-4 and ubiquitous factor NF-Y are critical for expression of blood coagulation factor X. J Biol Chem 1996; 271:2323-31.
-
(1996)
J Biol Chem
, vol.271
, pp. 2323-2331
-
-
Hung, H.L.1
High, K.A.2
-
71
-
-
0004118979
-
Characterization of a cDNA coding for human factor X
-
Leytus SP, Chung DW, Kisiel W, Kurachi K, Davie EW Characterization of a cDNA coding for human factor X. Proc Natl Acad Sci USA 1984; 81:3699-702.
-
(1984)
Proc Natl Acad Sci USA
, vol.81
, pp. 3699-3702
-
-
Leytus, S.P.1
Chung, D.W.2
Kisiel, W.3
Kurachi, K.4
Davie, E.W.5
-
72
-
-
0343505606
-
Characterization of an almost full-length cDNA coding for human blood coagulation factor X
-
Fung MR, Hay CW, MacGillivray RTA. Characterization of an almost full-length cDNA coding for human blood coagulation factor X. Proc Natl Acad Sci USA 1985; 82:3591-5.
-
(1985)
Proc Natl Acad Sci USA
, vol.82
, pp. 3591-3595
-
-
Fung, M.R.1
Hay, C.W.2
MacGillivray, R.T.A.3
-
73
-
-
85069111608
-
Functional characterization of the 5′ regulatory region of the human factor X gene
-
Huang M-N, High KA. Functional characterization of the 5′ regulatory region of the human factor X gene. Thromb Haemost 1991; 65:726.
-
(1991)
Thromb Haemost
, vol.65
, pp. 726
-
-
Huang, M.-N.1
High, K.A.2
-
76
-
-
0000436892
-
Stuart clotting defect. Segregation of a hereditary hemorrhagic state from the heterozygous heretofore called 'stable factor' (SPCA, proconvertin factor VII deficiency)
-
Hougie C, Barrow HM, Graham JB. Stuart clotting defect. Segregation of a hereditary hemorrhagic state from the heterozygous heretofore called 'stable factor' (SPCA, proconvertin factor VII deficiency). J Clin Invest 1957; 36:485-93.
-
(1957)
J Clin Invest
, vol.36
, pp. 485-493
-
-
Hougie, C.1
Barrow, H.M.2
Graham, J.B.3
-
77
-
-
0018672139
-
Combined functional and immunochemical analysis of normal and abnormal human factor X
-
Fair DS, Plow EF, Edgington TS. Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest 1979; 64:884-94.
-
(1979)
J Clin Invest
, vol.64
, pp. 884-894
-
-
Fair, D.S.1
Plow, E.F.2
Edgington, T.S.3
-
78
-
-
0024402803
-
Partial gene deletion in a family with factor X deficiency
-
Bernardi F, Marchetti G, Patracchini P, Volinia S, Gemmati D, Simioni P, Girolami A. Partial gene deletion in a family with factor X deficiency. Blood 1989; 73:2123-7.
-
(1989)
Blood
, vol.73
, pp. 2123-2127
-
-
Bernardi, F.1
Marchetti, G.2
Patracchini, P.3
Volinia, S.4
Gemmati, D.5
Simioni, P.6
Girolami, A.7
-
79
-
-
0026092852
-
Molecular genetic analysis of factor X deficiency:gene deletion and germline mosaicism
-
Wieland K, Millar DS, Grundy CB, Mibashan RS, Kakkar VV, Cooper DN. Molecular genetic analysis of factor X deficiency:gene deletion and germline mosaicism. Hum Genet 1991; 86:273-8.
-
(1991)
Hum Genet
, vol.86
, pp. 273-278
-
-
Wieland, K.1
Millar, D.S.2
Grundy, C.B.3
Mibashan, R.S.4
Kakkar, V.V.5
Cooper, D.N.6
-
81
-
-
0014834193
-
A new congenital haemorrhagic condition due to the presence of an abnormal factor X (Factor X Friuli). Study of a large kindred
-
Girolami A, Molaro G, Lazzarin M, Brunetti A, Scarpa R. A new congenital haemorrhagic condition due to the presence of an abnormal factor X (Factor X Friuli). Study of a large kindred. Br J Haematol 1970; 19:179-92.
-
(1970)
Br J Haematol
, vol.19
, pp. 179-192
-
-
Girolami, A.1
Molaro, G.2
Lazzarin, M.3
Brunetti, A.4
Scarpa, R.5
-
82
-
-
0014978576
-
Prothrombin level and activity in the abnormal factor X (Factor X Friuli) hemorrhagic disorder
-
Girolami A, Sticchi A, Brunetti A. Prothrombin level and activity in the abnormal factor X (Factor X Friuli) hemorrhagic disorder. Thromb Diath Haemhorrag 1971; 25:147-56.
-
(1971)
Thromb Diath Haemhorrag
, vol.25
, pp. 147-156
-
-
Girolami, A.1
Sticchi, A.2
Brunetti, A.3
-
84
-
-
0020662202
-
A family with heterozygous factor X Friuli defect outside Friuli
-
Girolami A, Lazzarin M, Procidano M, Luzzatto G. A family with heterozygous factor X Friuli defect outside Friuli. Blut 1983; 46: 149-55.
-
(1983)
Blut
, vol.46
, pp. 149-155
-
-
Girolami, A.1
Lazzarin, M.2
Procidano, M.3
Luzzatto, G.4
-
86
-
-
0024410307
-
Isolation and characterization of the factor X Friuli variant
-
Fair DS, Revak DJ, Hubbard JG, Girolami A. Isolation and characterization of the factor X Friuli variant. Blood 1989; 73:2108-16.
-
(1989)
Blood
, vol.73
, pp. 2108-2116
-
-
Fair, D.S.1
Revak, D.J.2
Hubbard, J.G.3
Girolami, A.4
-
87
-
-
0029990233
-
Characterization of recombinant human coagulation factor X Friuli
-
Kim DJ, Girolami A, James HL. Characterization of recombinant human coagulation factor X Friuli. Thromb Haemost 1996; 75: 313-7.
-
(1996)
Thromb Haemost
, vol.75
, pp. 313-317
-
-
Kim, D.J.1
Girolami, A.2
James, H.L.3
-
88
-
-
0026020326
-
Molecular defect in coagulation factor X Friuli results from a substitution of serine for proline at position 343
-
James HL, Girolami A, Fair DS. Molecular defect in coagulation factor X Friuli results from a substitution of serine for proline at position 343. Blood 1991; 77:317-23.
-
(1991)
Blood
, vol.77
, pp. 317-323
-
-
James, H.L.1
Girolami, A.2
Fair, D.S.3
-
89
-
-
0029661263
-
Factor X St Louis II. Identification of a glycine substitution at residue 7 and characterization of the recombinant protein
-
Rudolph AE, Mullane MP, Porche-Sorbet R, Tsuda S, Miletich JP. Factor X St Louis II. Identification of a glycine substitution at residue 7 and characterization of the recombinant protein. J Biol Chem 1996; 271:28601-6.
-
(1996)
J Biol Chem
, vol.271
, pp. 28601-28606
-
-
Rudolph, A.E.1
Mullane, M.P.2
Porche-Sorbet, R.3
Tsuda, S.4
Miletich, J.P.5
-
90
-
-
0029926277
-
Haemophilia B (sixth edition): A database of point mutations and short additions and deletions
-
Giannelli F, Green PM, Sommer SS, Poon M-C, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG. Haemophilia B (sixth edition): a database of point mutations and short additions and deletions. Nucleic Acids Res 24: 103-18.
-
Nucleic Acids Res
, vol.24
, pp. 103-118
-
-
Giannelli, F.1
Green, P.M.2
Sommer, S.S.3
Poon, M.-C.4
Ludwig, M.5
Schwaab, R.6
Reitsma, P.H.7
Goossens, M.8
Yoshioka, A.9
Brownlee, G.G.10
-
92
-
-
0009742233
-
Molecular defect (Gla26-Asp) and its functional consequences in a hereditary factor X deficiency (Factor X Malmo 4)
-
Wallmark A, Larson P, Ljung R, Monroe D, High K. Molecular defect (Gla26-Asp) and its functional consequences in a hereditary factor X deficiency (Factor X Malmo 4). Blood 1991; 78 Suppl. 1:60a.
-
(1991)
Blood
, vol.78
, Issue.1 SUPPL.
-
-
Wallmark, A.1
Larson, P.2
Ljung, R.3
Monroe, D.4
High, K.5
-
93
-
-
0023789852
-
Factor X Roma: A congenital factor X variant defective at different degrees in the intrinsic and the extrinsic activation
-
De Stefano V, Leone G, Ferrelli R, Hassan HJ, Macioce G, Bizzi B. Factor X Roma: a congenital factor X variant defective at different degrees in the intrinsic and the extrinsic activation. Brit J Haematol 1988; 69:387-91.
-
(1988)
Brit J Haematol
, vol.69
, pp. 387-391
-
-
De Stefano, V.1
Leone, G.2
Ferrelli, R.3
Hassan, H.J.4
Macioce, G.5
Bizzi, B.6
-
94
-
-
0028231019
-
Five novel point mutations:two causing haemophilia B and three causing factor X deficiency
-
Odom MW, Leone G, De Stefano V, Montiel MM, Boland EJ, Anderson J, Jagadeeswaran P. Five novel point mutations:two causing haemophilia B and three causing factor X deficiency. Molec Cell Probes 1994; 8:63-5.
-
(1994)
Molec Cell Probes
, vol.8
, pp. 63-65
-
-
Odom, M.W.1
Leone, G.2
De Stefano, V.3
Montiel, M.M.4
Boland, E.J.5
Anderson, J.6
Jagadeeswaran, P.7
-
95
-
-
0029640083
-
Factors X Wenatchee I and II:Compound heterozygosity involving two variant proteins
-
Kim DJ, Thompson AR, Nash DR, James HL. Factors X Wenatchee I and II:compound heterozygosity involving two variant proteins. Biochim Biophys Acta 1995; 1271:327-34.
-
(1995)
Biochim Biophys Acta
, vol.1271
, pp. 327-334
-
-
Kim, D.J.1
Thompson, A.R.2
Nash, D.R.3
James, H.L.4
-
97
-
-
0029918581
-
Factor X Stockton: A mild bleeding diathesis associated with an active site mutation in factor X
-
Messier TL, Wong CY, Bovill EG, Long GL, Church WR. Factor X Stockton: a mild bleeding diathesis associated with an active site mutation in factor X. Blood Coag Fibrinol 1996; 7: 5-14.
-
(1996)
Blood Coag Fibrinol
, vol.7
, pp. 5-14
-
-
Messier, T.L.1
Wong, C.Y.2
Bovill, E.G.3
Long, G.L.4
Church, W.R.5
-
98
-
-
0025282475
-
+14→Lys) and its functional consequences in a hereditary factor X deficiency (Factor X "Vorarlberg")
-
+14→Lys) and its functional consequences in a hereditary factor X deficiency (Factor X "Vorarlberg"). J Biol Chem 1990; 265:11982-9.
-
(1990)
J Biol Chem
, vol.265
, pp. 11982-11989
-
-
Watzke, H.H.1
Lechner, K.2
Roberts, H.R.3
Reddy, S.V.4
Wesch, D.J.5
Friedman, P.6
Mahr, G.7
Jagadeeswaran, P.8
Monroe, D.M.9
High, K.A.10
-
99
-
-
0028984931
-
Factor X Ketchikan: A variant molecule in which Gly replaces a Gla residue at position 14 in the light chain
-
Kim DJ, Thompson AR, James HL. Factor X Ketchikan: a variant molecule in which Gly replaces a Gla residue at position 14 in the light chain. Hum Genet 1995; 95:212-4.
-
(1995)
Hum Genet
, vol.95
, pp. 212-214
-
-
Kim, D.J.1
Thompson, A.R.2
James, H.L.3
-
100
-
-
0025919758
-
Factor X Santo Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion
-
Watzke HH, Wallmark A, Hamaguchi N, Giardina P, Stafford DW, High KA. Factor X Santo Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion. J Clin Invest 1991; 88:1685-9.
-
(1991)
J Clin Invest
, vol.88
, pp. 1685-1689
-
-
Watzke, H.H.1
Wallmark, A.2
Hamaguchi, N.3
Giardina, P.4
Stafford, D.W.5
High, K.A.6
-
101
-
-
0027471438
-
Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum
-
Racchi M, Watzke HH, High KA, Lively MO. Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum. J Biol Chem 1993; 268:5735-40.
-
(1993)
J Biol Chem
, vol.268
, pp. 5735-5740
-
-
Racchi, M.1
Watzke, H.H.2
High, K.A.3
Lively, M.O.4
-
102
-
-
0025503855
-
Targeting of proteins into the eukaryotic secretory pathway: Signal peptide structure/function relationships
-
Nothwehr SF, Gordon JI. Targeting of proteins into the eukaryotic secretory pathway: signal peptide structure/function relationships. BioEssays 1990; 12:479-84.
-
(1990)
BioEssays
, vol.12
, pp. 479-484
-
-
Nothwehr, S.F.1
Gordon, J.I.2
-
103
-
-
0025287330
-
Comparative modelling methods:Application to the family of the mammalian serine proteases
-
Greer J. Comparative modelling methods:application to the family of the mammalian serine proteases. Proteins Struct Funct Genet 1990; 7:317-34.
-
(1990)
Proteins Struct Funct Genet
, vol.7
, pp. 317-334
-
-
Greer, J.1
-
104
-
-
0001146461
-
Molecular defect in F.X 'Öckerö', a mild congenital F.X deficiency
-
Wallmark A, Ho C, Monroe DM, Tengborn L, High KA. Molecular defect in F.X 'Öckerö', a mild congenital F.X deficiency. Thromb Haemost 1991; 65:1263.
-
(1991)
Thromb Haemost
, vol.65
, pp. 1263
-
-
Wallmark, A.1
Ho, C.2
Monroe, D.M.3
Tengborn, L.4
High, K.A.5
-
105
-
-
0029112076
-
Molecular bases of CRM+ factor X deficiency:A frequent mutation (Ser334Pro) in the catalytic domain and substitution (Glu102Lys) in the second EGF-like domain
-
Marchetti G, Castaman G, Pinotti M, Lunghi B, Di Iasio MG, Ruggieri M, Rodeghiero F, Bernardi F. Molecular bases of CRM+ factor X deficiency:a frequent mutation (Ser334Pro) in the catalytic domain and substitution (Glu102Lys) in the second EGF-like domain. Brit J Haematol 1995; 90:910-5.
-
(1995)
Brit J Haematol
, vol.90
, pp. 910-915
-
-
Marchetti, G.1
Castaman, G.2
Pinotti, M.3
Lunghi, B.4
Di Iasio, M.G.5
Ruggieri, M.6
Rodeghiero, F.7
Bernardi, F.8
-
107
-
-
0024292694
-
Molecular basis of coagulation
-
Furie B, Furie BC. Molecular basis of coagulation. Cell 1988; 53:505-18.
-
(1988)
Cell
, vol.53
, pp. 505-518
-
-
Furie, B.1
Furie, B.C.2
-
108
-
-
0021112692
-
Beta-hydroxyaspartic acid in vitamin K-dependent proteins
-
Fernlund P, Stenflo J. Beta-hydroxyaspartic acid in vitamin K-dependent proteins. J Biol Chem 1983; 258:12509-12.
-
(1983)
J Biol Chem
, vol.258
, pp. 12509-12512
-
-
Fernlund, P.1
Stenflo, J.2
-
109
-
-
0028929274
-
Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site
-
Nakagawa H, Takahashi N, Fujikawa K, Kawamura Y, Iino M, Takeya H, Ogawa H, Suzuki K. Identification of the oligosaccharide structures of human coagulation factor X activation peptide at each glycosylation site. Glycoconjugate J 1995; 12:173-81.
-
(1995)
Glycoconjugate J
, vol.12
, pp. 173-181
-
-
Nakagawa, H.1
Takahashi, N.2
Fujikawa, K.3
Kawamura, Y.4
Iino, M.5
Takeya, H.6
Ogawa, H.7
Suzuki, K.8
-
110
-
-
0027537465
-
Carbohydrate residues modulate the activation of coagulation factor X
-
Sinha U, Wolf DL. Carbohydrate residues modulate the activation of coagulation factor X. J Biol Chem 1993; 268:3048-51.
-
(1993)
J Biol Chem
, vol.268
, pp. 3048-3051
-
-
Sinha, U.1
Wolf, D.L.2
-
111
-
-
0028968261
-
Enzymatic removal of sialic acid from human factor IX and factor X has no effect on their coagulant activity
-
Bharadwaj D, Harris RJ, Kisiel W, Smith KJ. Enzymatic removal of sialic acid from human factor IX and factor X has no effect on their coagulant activity. J Biol Chem 1995; 270:6537-42.
-
(1995)
J Biol Chem
, vol.270
, pp. 6537-6542
-
-
Bharadwaj, D.1
Harris, R.J.2
Kisiel, W.3
Smith, K.J.4
-
112
-
-
0023239941
-
The factor IX phospholipid-binding site is required for calcium-dependent activation of factor factor IX by factor XIa
-
Liebman HA, Furie BC, Furie B. The factor IX phospholipid-binding site is required for calcium-dependent activation of factor factor IX by factor XIa. J Biol Chem 1986; 262:7605-12.
-
(1986)
J Biol Chem
, vol.262
, pp. 7605-7612
-
-
Liebman, H.A.1
Furie, B.C.2
Furie, B.3
-
113
-
-
0022979292
-
Preparation and properties of derivatives of bovine factor X and factor Xa from which the γ-carboxyglutamic acid domain has been removed
-
Morita T, Jackson CM. Preparation and properties of derivatives of bovine factor X and factor Xa from which the γ-carboxyglutamic acid domain has been removed. J Biol Chem 1986; 261:4015-23.
-
(1986)
J Biol Chem
, vol.261
, pp. 4015-4023
-
-
Morita, T.1
Jackson, C.M.2
-
114
-
-
0024454718
-
Calcium binding to the isolated β-hydroxyaspartic acid-containing epidermal growth factor-like domain of bovine factor X
-
Persson E, Selander M, Linse S, Drakenberg T, Ohlin A-K, Stenflo J. Calcium binding to the isolated β-hydroxyaspartic acid-containing epidermal growth factor-like domain of bovine factor X. J Biol Chem 1989; 264:16897-904.
-
(1989)
J Biol Chem
, vol.264
, pp. 16897-16904
-
-
Persson, E.1
Selander, M.2
Linse, S.3
Drakenberg, T.4
Ohlin, A.-K.5
Stenflo, J.6
-
115
-
-
0027371840
-
The effect of aspartate hydroxylation on calcium binding to epidermal growth factor-like modules in coagulation factors IX and X
-
Selander-Sunnerhagen M, Persson E, Dahlqvist I, Drakenberg T, Mayhew M, Robin M, Handford P, Tilley JW, Campbell ID, Brownlee GG. The effect of aspartate hydroxylation on calcium binding to epidermal growth factor-like modules in coagulation factors IX and X. J Biol Chem 1993; 268:23339-44.
-
(1993)
J Biol Chem
, vol.268
, pp. 23339-23344
-
-
Selander-Sunnerhagen, M.1
Persson, E.2
Dahlqvist, I.3
Drakenberg, T.4
Mayhew, M.5
Robin, M.6
Handford, P.7
Tilley, J.W.8
Campbell, I.D.9
Brownlee, G.G.10
-
116
-
-
0028172935
-
Calcium-dependent interaction between γ-carboxyglutamic acid-containing and N-terminal epidermal growth factor-like modules in factor X
-
Valcarce C, Holmgren A, Stenflo J. Calcium-dependent interaction between γ-carboxyglutamic acid-containing and N-terminal epidermal growth factor-like modules in factor X. J Biol Chem 269:26011-6.
-
J Biol Chem
, vol.269
, pp. 26011-26016
-
-
Valcarce, C.1
Holmgren, A.2
Stenflo, J.3
-
118
-
-
0028790160
-
Functional consequences of the Ser334→Pro mutation in a human factor X variant (factor X Marseille)
-
Bezeaud A, Miyata T, Helley D, Zeng YZ, Kato H, Aillaud MF, Juhan-Vague I, Guillin MC. Functional consequences of the Ser334→Pro mutation in a human factor X variant (factor X Marseille). Eur J Biochem 1995; 234:140-7.
-
(1995)
Eur J Biochem
, vol.234
, pp. 140-147
-
-
Bezeaud, A.1
Miyata, T.2
Helley, D.3
Zeng, Y.Z.4
Kato, H.5
Aillaud, M.F.6
Juhan-Vague, I.7
Guillin, M.C.8
|